• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

美国符合接受 PrEP 治疗的跨性别女性中的预防有效坚持轨迹:一项前瞻性队列研究。

Prevention-effective adherence trajectories among transgender women indicated for PrEP in the United States: a prospective cohort study.

机构信息

Johns Hopkins Bloomberg School of Public Health, Department of International Health, Baltimore, MD.

Fenway Health, The Fenway Institute, Boston, MA; Brigham and Women's Hospital, Division of Endocrinology, Diabetes, and Hypertension, Boston, MA; Harvard Medical School, Department of Medicine, Boston, MA; Harvard TH Chan School of Public Health, Department of Epidemiology, Boston, MA.

出版信息

Ann Epidemiol. 2022 Jun;70:23-31. doi: 10.1016/j.annepidem.2022.03.016. Epub 2022 Apr 6.

DOI:10.1016/j.annepidem.2022.03.016
PMID:35398255
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9167788/
Abstract

PURPOSE

Adherence to pre-exposure prophylaxis (PrEP) during periods of PrEP-indication (i.e., prevention-effective adherence) is critical for preventing HIV. We sought to describe factors associated with prevention-effective adherence trajectories among transgender women (TW) to inform PrEP implementation strategies.

METHODS

Using data from The LITE American Cohort (n = 728), we performed group-based multi-trajectory modeling (GBMTM) to identify clusters of TW with similar trajectories of PrEP adherence and indication, and sociodemographic, biobehavioral, and structural correlates of each trajectory.

RESULTS

We identified five trajectories: (1) consistent indication/no PrEP (15.3%), (2) initial indication/no PrEP (47.1%), (3) declining indication/discontinued PrEP (9.5%), (4) consistent indication/PrEP adherent (18.5%), and (5) increasing indication/initiated PrEP (9.6%). TW diagnosed with an STI were more likely to follow a consistent indication/no PrEP trajectory compared to consistent indication/PrEP adherent trajectory (adjusted Relative Risk Ratio [aRRR], 2.54; 95% confidence interval [CI], 1.16-5.57). TW who experienced homelessness were more likely to follow PrEP discontinuation and initiation trajectories relative to PrEP adherence (aRRR, 2.71; 95% CI, 1.10-6.70 and 2.83; 95% CI, 1.13-7.05, respectively).

CONCLUSIONS

Over a quarter of TW followed trajectories suggestive of prevention-effective adherence, while 15% did not initiate PrEP despite consistent indication. Findings highlight missed opportunities for PrEP engagement at STI diagnosis and suggest structural interventions addressing housing instability may improve prevention-effective adherence among TW.

摘要

目的

在有预防指征(即有效预防依从性)期间坚持使用暴露前预防(PrEP)对于预防 HIV 至关重要。我们旨在描述与跨性别女性(TW)的有效预防依从轨迹相关的因素,以为 PrEP 实施策略提供信息。

方法

使用来自 LITE 美国队列(n=728)的数据,我们进行了基于群组的多轨迹建模(GBMTM),以识别 PrEP 依从性和指征具有相似轨迹的 TW 群组,并确定每个轨迹的社会人口统计学、生物行为学和结构相关性。

结果

我们确定了五个轨迹:(1)持续指征/无 PrEP(15.3%),(2)初始指征/无 PrEP(47.1%),(3)指征减少/停止 PrEP(9.5%),(4)持续指征/PrEP 依从性(18.5%)和(5)指征增加/开始 PrEP(9.6%)。与持续指征/PrEP 依从性轨迹相比,诊断出性传播感染(STI)的 TW 更有可能遵循持续指征/无 PrEP 轨迹(调整后的相对风险比 [aRRR],2.54;95%置信区间 [CI],1.16-5.57)。经历过无家可归的 TW 更有可能遵循 PrEP 停药和启动轨迹,而不是 PrEP 依从性(aRRR,2.71;95%CI,1.10-6.70 和 2.83;95%CI,1.13-7.05)。

结论

超过四分之一的 TW 遵循了提示有效预防依从性的轨迹,而 15%的 TW 尽管有持续指征,但仍未开始使用 PrEP。这些发现突出了在 STI 诊断时错过 PrEP 参与的机会,并表明解决住房不稳定的结构性干预措施可能会提高 TW 的有效预防依从性。

相似文献

1
Prevention-effective adherence trajectories among transgender women indicated for PrEP in the United States: a prospective cohort study.美国符合接受 PrEP 治疗的跨性别女性中的预防有效坚持轨迹:一项前瞻性队列研究。
Ann Epidemiol. 2022 Jun;70:23-31. doi: 10.1016/j.annepidem.2022.03.016. Epub 2022 Apr 6.
2
PrEP initiation and discontinuation among transgender women in the United States: a longitudinal, mixed methods cohort study.美国跨性别女性中的 PrEP 起始和停药:一项纵向、混合方法队列研究。
J Int AIDS Soc. 2023 Dec;26(12):e26199. doi: 10.1002/jia2.26199.
3
Perceived HIV Acquisition Risk and Low Uptake of PrEP Among a Cohort of Transgender Women With PrEP Indication in the Eastern and Southern United States.在美国东部和南部,有一个有接受 PrEP 指征的跨性别女性队列,她们感知到的 HIV 获得风险和 PrEP 的低使用率。
J Acquir Immune Defic Syndr. 2021 Sep 1;88(1):10-18. doi: 10.1097/QAI.0000000000002726.
4
Factors associated with long-term HIV pre-exposure prophylaxis engagement and adherence among transgender women in Brazil, Mexico and Peru: results from the ImPrEP study.巴西、墨西哥和秘鲁跨性别女性中与长期 HIV 暴露前预防参与和坚持相关的因素:ImPrEP 研究结果。
J Int AIDS Soc. 2022 Oct;25 Suppl 5(Suppl 5):e25974. doi: 10.1002/jia2.25974.
5
HIV awareness and prevention strategies among transgender women in the Eastern and Southern United States: findings from the LITE Study.美国东部和南部跨性别女性的艾滋病认知和预防策略:LITE 研究的结果。
J Int AIDS Soc. 2022 Oct;25 Suppl 5(Suppl 5):e25999. doi: 10.1002/jia2.25999.
6
Dismantling Barriers and Transforming the Future of Pre-Exposure Prophylaxis Uptake in Young Black and Latinx Sexual Minority Men and Transgender Women.消除障碍,改变年轻的黑人和拉丁裔性少数男性和跨性别女性接受暴露前预防的未来。
AIDS Patient Care STDS. 2022 May;36(5):194-203. doi: 10.1089/apc.2021.0222.
7
HIV pre-exposure prophylaxis in transgender women: a subgroup analysis of the iPrEx trial.HIV 暴露前预防在跨性别女性中的应用:iPrEx 试验的亚组分析。
Lancet HIV. 2015 Dec;2(12):e512-9. doi: 10.1016/S2352-3018(15)00206-4. Epub 2015 Nov 6.
8
PrEP Use and Adherence among Transgender Persons in Chicago, IL (SHIPP Study, 2014-2018, USA).芝加哥跨性别者的 HIV 预防用药(PrEP)使用和依从性(SHIPP 研究,2014-2018,美国)。
AIDS Behav. 2023 Mar;27(3):901-908. doi: 10.1007/s10461-022-03826-y. Epub 2022 Sep 12.
9
Retention, engagement, and adherence to pre-exposure prophylaxis for men who have sex with men and transgender women in PrEP Brasil: 48 week results of a demonstration study.《PrEP Brasil 中男男性行为者和跨性别女性人群使用暴露前预防的保留率、参与率和坚持率:一项示范研究的 48 周结果》
Lancet HIV. 2018 Mar;5(3):e136-e145. doi: 10.1016/S2352-3018(18)30008-0. Epub 2018 Feb 18.
10
Adherence to Oral Pre-Exposure Prophylaxis Intervention by Transgender Women: A Systematic Review.跨性别女性对口服暴露前预防干预的依从性:系统评价。
AIDS Educ Prev. 2023 Oct;35(5):362-375. doi: 10.1521/aeap.2023.35.5.362.

引用本文的文献

1
High syphilis incidence among PrEP-adherent men who have sex with men and transgender women in Peru.在秘鲁,坚持使用暴露前预防药物的男男性行为者和跨性别女性中梅毒发病率较高。
J Int AIDS Soc. 2025 Sep;28(9):e70002. doi: 10.1002/jia2.70002.
2
Social determinants of HIV status and viral load suppression among transgender women in South Africa: a cross-sectional analysis.南非跨性别女性中艾滋病毒感染状况和病毒载量抑制的社会决定因素:一项横断面分析。
AIDS Care. 2025 Sep;37(9):1507-1520. doi: 10.1080/09540121.2025.2535471. Epub 2025 Jul 26.
3
Brief Report: Interest in Long-acting Injectable PrEP Among Transgender Women in Eastern and Southern United States.

本文引用的文献

1
The spatiotemporal distribution of pre-exposure prophylaxis accessibility in the United States, 2016-2020.2016-2020 年美国暴露前预防可及性的时空分布。
Ann Epidemiol. 2021 Dec;64:102-110. doi: 10.1016/j.annepidem.2021.09.006. Epub 2021 Sep 24.
2
Digital Epidemiologic Research on Multilevel Risks for HIV Acquisition and Other Health Outcomes Among Transgender Women in Eastern and Southern United States: Protocol for an Online Cohort.美国东部和南部跨性别女性中获得艾滋病毒及其他健康结果的多层次风险的数字流行病学研究:在线队列研究方案
JMIR Res Protoc. 2021 Apr 26;10(4):e29152. doi: 10.2196/29152.
3
Changes in Sexual Behavior, PrEP Adherence, and Access to Sexual Health Services Because of the COVID-19 Pandemic Among a Cohort of PrEP-Using MSM in the South.
简短报告:美国东部和南部跨性别女性对长效注射用暴露前预防药物的兴趣
J Acquir Immune Defic Syndr. 2024 Sep 1;97(1):19-25. doi: 10.1097/QAI.0000000000003465.
4
"When Somebody Comes into This Country and You Are Trans on Top of That Is Like You Got… Two Strikes on You": Intersectional Barriers to PrEP Use Among Latina Transgender Women in the Eastern and Southern United States.“当有人进入这个国家,而你还是跨性别者,那就好比你……有了两次不利因素”:美国东部和南部拉丁裔跨性别女性在使用暴露前预防药物方面面临的交叉性障碍
Int J Environ Res Public Health. 2025 Apr 22;22(5):659. doi: 10.3390/ijerph22050659.
5
PrEP Use Among Black Transgender Women: A Qualitative Study on Barriers to PrEP Use and the Power and Promise of Community.黑人跨性别女性中的暴露前预防用药情况:关于暴露前预防用药障碍以及社区力量与前景的定性研究
Arch Sex Behav. 2025 Apr 22. doi: 10.1007/s10508-025-03130-5.
6
Lifetime homelessness among young transgender women in Lima, Peru is associated with HIV vulnerability: Results from a cross-sectional survey.秘鲁利马年轻跨性别女性中的终身无家可归状况与感染艾滋病毒的易感性相关:一项横断面调查结果
PLOS Glob Public Health. 2025 Apr 21;5(4):e0004351. doi: 10.1371/journal.pgph.0004351. eCollection 2025.
7
The Association Between Use of Adherence Support Interventions and Adherence to HIV Preexposure Prophylaxis Among Young South African and Zimbabwean Women in HPTN 082.在HPTN 082研究中,南非和津巴布韦年轻女性使用依从性支持干预措施与坚持HIV暴露前预防之间的关联
AIDS Behav. 2025 Apr 10. doi: 10.1007/s10461-025-04709-8.
8
Preferences and willingness for starting daily, on-demand, and long-acting injectable HIV pre-exposure prophylaxis among transfeminine persons in the US, 2022-2023.2022 - 2023年美国跨性别女性中对开始每日、按需和长效注射用艾滋病毒暴露前预防的偏好与意愿
PLoS One. 2025 Apr 1;20(4):e0320961. doi: 10.1371/journal.pone.0320961. eCollection 2025.
9
Preference for Long-Acting Injectable PrEP Compared With Daily Oral PrEP Among Transgender Women in the U.S.: Findings From a Multisite Cohort.美国跨性别女性中长效注射用暴露前预防药物与每日口服暴露前预防药物的偏好比较:多中心队列研究结果
AJPM Focus. 2025 Jan 8;4(2):100313. doi: 10.1016/j.focus.2025.100313. eCollection 2025 Apr.
10
Preference for Long-Acting HIV Prevention Methods Among Transgender Women Vulnerable to HIV in Eastern and Southern United States: Findings from the LITE Study.美国东部和南部易感染艾滋病毒的跨性别女性对长效艾滋病毒预防方法的偏好:LITE研究结果
AIDS Behav. 2025 Mar;29(3):804-816. doi: 10.1007/s10461-024-04561-2. Epub 2024 Dec 5.
由于 COVID-19 大流行,南方接受 PrEP 的男男性行为者人群中的性行为变化、PrEP 依从性和获得性健康服务的机会。
J Acquir Immune Defic Syndr. 2021 May 1;87(1):639-643. doi: 10.1097/QAI.0000000000002640.
4
Archives at 50 Years.50年的档案。
Arch Sex Behav. 2021 Jan;50(1):1-6. doi: 10.1007/s10508-021-01913-0.
5
Preexposure prophylaxis care continuum among transgender women at a patient-centered preexposure prophylaxis program in Atlanta, Georgia.佐治亚州亚特兰大一个以患者为中心的暴露前预防项目中,跨性别女性的暴露前预防护理连续过程。
AIDS. 2021 Mar 1;35(3):524-526. doi: 10.1097/QAD.0000000000002788.
6
"I wish to remain HIV negative": Pre-exposure prophylaxis adherence and persistence in transgender women and men who have sex with men in coastal Kenya.“我希望保持 HIV 阴性”:肯尼亚沿海地区跨性别女性和男男性行为者的暴露前预防依从性和持续性。
PLoS One. 2021 Jan 19;16(1):e0244226. doi: 10.1371/journal.pone.0244226. eCollection 2021.
7
Disparities in the PrEP continuum for trans women compared to MSM in San Francisco, California: results from population-based cross-sectional behavioural surveillance studies.加利福尼亚州旧金山地区跨性别女性与男男性行为者之间的 HIV 暴露前预防连续性服务差距:基于人群的横断面行为监测研究结果。
J Int AIDS Soc. 2020 Jun;23 Suppl 3(Suppl 3):e25539. doi: 10.1002/jia2.25539.
8
American Cohort to Study HIV Acquisition Among Transgender Women in High-Risk Areas (The LITE Study): Protocol for a Multisite Prospective Cohort Study in the Eastern and Southern United States.美国高危地区跨性别女性中HIV感染情况队列研究(LITE研究):美国东部和南部多中心前瞻性队列研究方案
JMIR Res Protoc. 2019 Oct 3;8(10):e14704. doi: 10.2196/14704.
9
"Some of us, we don't know where we're going to be tomorrow." Contextual factors affecting PrEP use and adherence among a diverse sample of transgender women in San Francisco.我们中的一些人,不知道明天会身在何处。旧金山不同类型跨性别女性中影响暴露前预防用药使用及依从性的情境因素
AIDS Care. 2020 May;32(5):585-593. doi: 10.1080/09540121.2019.1659912. Epub 2019 Sep 4.
10
A Promising PrEP Navigation Intervention for Transgender Women and Men Who Have Sex with Men Experiencing Multiple Syndemic Health Disparities.一种有前途的预防经性途径感染(PrEP)导航干预措施,适用于经历多种综合征健康不平等的跨性别女性和男男性行为者。
J Community Health. 2019 Dec;44(6):1193-1203. doi: 10.1007/s10900-019-00705-x.